BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Ghaziani T, Sendi H, Shahraz S, Zamor P, Bonkovsky HL. Hepatitis B and liver transplantation: Molecular and clinical features that influence recurrence and outcome. World J Gastroenterol 2014; 20(39): 14142-14155 [PMID: 25339803 DOI: 10.3748/wjg.v20.i39.14142]
URL: https://www.wjgnet.com/1948-5182/full/v20/i39/14142.htm
Number Citing Articles
1
Non-Neoplastic Diseases of the Liver2022; : 353 doi: 10.55418/9781933477183-11
2
Peter Schemmer, Patrizia Burra, Rey‐Heng Hu, Christian M. Hüber, Carmelo Loinaz, Keigo Machida, Arndt Vogel, Didier Samuel. State of the art treatment of hepatitis B virus hepatocellular carcinoma and the role of hepatitis B surface antigen post‐liver transplantation and resectionLiver International 2022; 42(2): 288 doi: 10.1111/liv.15124
3
Miguel Jiménez-Pérez, Rocío González-Grande, José Mostazo Torres, Carolina González Arjona, Francisco Javier Rando-Muñoz. Management of hepatitis B virus infection after liver transplantationWorld Journal of Gastroenterology 2015; 21(42): 12083-12090 doi: 10.3748/wjg.v21.i42.12083
4
Jessica M Sido, Prakash S Nagarkatti, Mitzi Nagarkatti. Δ9-Tetrahydrocannabinol attenuates allogeneic host-versus-graft response and delays skin graft rejection through activation of cannabinoid receptor 1 and induction of myeloid-derived suppressor cellsJournal of Leukocyte Biology 2015; 98(3): 435 doi: 10.1189/jlb.3A0115-030RR
5
Afroditi Orfanidou, George V. Papatheodoridis, Evangelos Cholongitas. Antiviral prophylaxis against hepatitis B recurrence after liver transplantation: Current conceptsLiver International 2021; 41(7): 1448 doi: 10.1111/liv.14860
6
Di Lu, Jianyong Zhuo, Modan Yang, Chao Wang, Linhui Pan, Haiyang Xie, Xiao Xu, Shusen Zheng. The association between donor genetic variations in one-carbon metabolism pathway genes and hepatitis B recurrence after liver transplantationGene 2018; 663: 121 doi: 10.1016/j.gene.2018.03.071
7
Mariana Mihăilă, Cristina Mădălina Pascu, Andreea Andrunache, Cătălin Ștefan Ghenea. Antiviral Strategies in the Treatment of Human and Animal Viral InfectionsInfectious Diseases 2023; 27 doi: 10.5772/intechopen.112502
8
Bruno Roche, Anne Marie Roque-Afonso, Frederik Nevens, Didier Samuel. Rational Basis for Optimizing Short and Long-term Hepatitis B Virus Prophylaxis Post Liver TransplantationTransplantation 2015; 99(7): 1321 doi: 10.1097/TP.0000000000000777
9
Wei Jiang, John L. Farber. Contemporary Liver Transplantation2017; : 355 doi: 10.1007/978-3-319-07209-8_21
10
Gary C. Kanel. Atlas of Liver Pathology2024; : 445 doi: 10.1016/B978-0-323-82533-7.00013-2
11
Wei Jiang, John L. Farber. Contemporary Liver Transplantation2016; : 1 doi: 10.1007/978-3-319-05543-5_21-2
12
Sahar Janfeshan, Ramin Yaghobi, Akram Eidi, Mohammad Hossein Karimi, Bita Geramizadeh, Seyed Ali Malekhosseini, Farshid Kafilzadeh. Study the Cross-talk Between Hepatitis B Virus Infection and Interferon Regulatory Factors in Liver Transplant PatientsHepatitis Monthly 2017; 17(11) doi: 10.5812/hepatmon.12426
13
Hesham E. Eldin, Reham E. AlSwaff, Eslam Safwat, Moez M. El Imam. Serum adiponectin in Egyptian patients with chronic hepatitis B virus infectionEgyptian Liver Journal 2018; 8(2): 45 doi: 10.1097/01.ELX.0000547794.42254.91
14
Roberto Patron, Shimon Kusne, David Mulligan. Transplant Infections2016; : 215 doi: 10.1007/978-3-319-28797-3_14
15
A.J. Demetris, C.O.C. Bellamy, C.R. Gandhi, S. Prost, Y. Nakanuma, D.B. Stolz. Functional Immune Anatomy of the Liver—As an AllograftAmerican Journal of Transplantation 2016; 16(6): 1653 doi: 10.1111/ajt.13749
16
Ying Ma, Yujun Yuan, Xianglin Ma, Boru Tang, Ximei Hu, Juan Feng, Li Tian, Yaohua Ji, Xiaoguang Dou. Association between clinical features and YMDD mutations in patients with chronic hepatitis B following lamivudine therapyExperimental and Therapeutic Medicine 2016; 12(2): 847 doi: 10.3892/etm.2016.3365
17
Wei Jiang, John L. Farber. Contemporary Liver Transplantation2016; : 1 doi: 10.1007/978-3-319-05543-5_21-1